+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

From
Gastric Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Gastric Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 2657 Pages
  • Global
From
From
Viral Vector Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 250 Pages
  • Global
From
Iron Drugs Market 2024-2028 - Product Thumbnail Image

Iron Drugs Market 2024-2028

  • Report
  • June 2024
  • 174 Pages
  • Global
From
From
From
Nanopharmaceuticals - Thematic Research - Product Thumbnail Image

Nanopharmaceuticals - Thematic Research

  • Report
  • March 2020
  • 96 Pages
  • Global
From
Pulmonary Embolism Global Market Report 2024 - Product Thumbnail Image

Pulmonary Embolism Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Heart Failure: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Heart Failure: Global Drug Forecast and Market Analysis to 2028

  • Report
  • December 2019
  • 190 Pages
  • Global
From
From
Antithrombotic Drugs Market 2023-2027 - Product Thumbnail Image

Antithrombotic Drugs Market 2023-2027

  • Report
  • May 2023
  • 156 Pages
  • Global
From
From
Therapeutics for Women's Health: Technologies and Global Markets - Product Thumbnail Image

Therapeutics for Women's Health: Technologies and Global Markets

  • Report
  • January 2022
  • 258 Pages
  • Global
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 344 Pages
  • Global
From
From
Loading Indicator